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INTRODUCTION 
 
  
 The number of drugs and formulations introduced into the market 
is increasing every year. It is therefore, necessary to develop newer 
analytical methods for such drugs and formulations. The reasons for the 
development of newer methods of drug analysis are:- 
 
         The drug or drug combination may not be official in any 
pharmacopoeia. A proper analytical procedure for the drug may not be 
available in the literature due to patent regulations. 
 
 Analytical methods may not be available for the drug in the form 
of a formulation due to the interference caused by the formulation 
excipients. 
 Analytical methods for the quantification of the drug in biological 
fluids may not be available. 
 Analytical methods for a drug in combination with other drugs 
may not be available. 
 The existing analytical procedures may require expensive 
reagents and solvents. It may also involve cumbersome extraction 
and separation procedures and these may not be reliable. 
 
Estimation of drugs in single and multi component formulations: 
 
 Drugs are typically developed and manufactured into 
formulations prior to their use by patients. Very often administration of 
two or more drugs at a time becomes imperative for   several therapeutic 
reasons and there exist a number of drug combinations which have 
proved to have better therapeutic effect due to their synergistic effect, 
ease of administration as a single dose which also has a higher patient 
compliance and economy in production, distribution and treatment costs.
  
There are several methods of analysis of formulations, which 
include  
a)  Classical separation and analysis (non-instrumental):  
 It involves the separation of components of interest using the 
classical separation techniques like extraction or isolation and then a 
suitable estimation procedure is selected to quantify the individual 
components. It includes the techniques like gravimetry, volumetry, etc. 
 
b) Spectral Methods 
  In spectral techniques, the electro magnetic radiation that is either 
absorbed or emitted by the sample is measured. It includes the 
techniques like UV-visible spectroscopy, infrared spectroscopy, flame 
photometry, fluorimetry, etc. 
 
c)  Electro Analytical Methods 
 It involves the measurement of current, voltage or resistance as a 
property of the concentration of the drug in solution mixture. It includes 
the techniques like potentiometry conductometry, amperometry, etc. 
 
d)  Chromatographic Methods 
 The different chromatographic techniques available are thin layer 
chromatography, gas chromatography, column chromatography, paper 
chromatography, size exclusion chromatography, high performance 
liquid chromatography and high performance thin layer 
chromatography. The most reliable and widely used advanced 
chromatographic techniques for the estimation of drug in formulation 
are. 
 
 
i) Gas liquid chromatography (GLC)  
 In this technique, a carrier gas is used as the mobile phase and it 
passes over a stationary phase which is a non volatile liquid coated on 
an inert solid support. Separation takes place in accordance with the 
partition co-efficients of the components in the mixture. 
ii) High performance Liquid chromatography (HPLC) 
 The technique of high performance liquid chromatography is so 
called because of its improved performance when compared to classical 
column chromatography. 
iii) High Performance thin layer chromatography (HPTLC) 
 It is a sophisticated, advanced and automated version of thin layer 
chromatography. 
 
 
 
 
 
 
 
 
OBJECTIVE OF THE STUDY 
 
 
 The number of drugs and drug formulations introduced into the 
market is increasing at an alarming rate. The complexity of these dosage 
forms poses considerable challenge to the analytical chemist during the 
development of assay procedure. The estimation of individual drugs and 
multi component dosage forms become difficult due to cumbersome 
extraction and isolation procedure.  
For the estimation of the drugs present in formulations, methods 
like HPLC, HPTLC and spectrophotometric methods are more suitable 
since these methods are highly specific, linear, precise, accurate, 
sensitive and rapid. 
From the review of literature, we found no documentary evidence 
is available for the quantitative analysis of ternary mixture, Aceclofenac, 
paracetamol and chlorzoxazone. We also found that there is no reported 
method for the estimation of drugs by differential spectrometry.  
In the proposed work, we developed HPLC and HPTLC method 
to quantify aceclofenac in combination with paracetamol and 
chlorzoxazone and individually using differential spectroscopy. 
DRUG PROFILE 
ACECLOFENAC 
Aceclofenac is an analgesic and anti-inflammatory agent used to 
relive pain associated with inflammation. 
 
CHEMISTRY: 
Molecular formula  : C16 H13 NO4Cl2 
 
Chemical Name      : [(2-[(2,6-dichlorephenyl) amino] phenyl]                                 
          acetyl]oxy]acetic acid. 
Molecular weight  : 354.2 
Description   :   white or almost white crystalline powder 
Solubility                         :  Practically insoluble in water, freely soluble    
   in acetone, soluble in alcohol. 
This drug is official in B.P 2007 Volume –I 
 
 
Mechanism of Action: 
  Aceclofenac has been shown to exert effects on many mediators 
of inflammation. It inhibits the synthesis of inflammatory cytokinines, 
interleukin – 1b and tumour nerosis factor and inhibits prostaglandinE2 
production. It also stimulates glycosaminoglycans (GAG) synthesis, 
which aids in repair and regeneration of articular damage.  
 
Indications: 
 Management of osteoarthritis, rheumatoid arthritis and 
alkylyosing spondylitis.  
Dose: 
 Adults 100 mg b.i.d. 
 
 
CHLORZOXAZONE 
Chlorzoxazone is a centrally acting skeletal muscle relaxant. 
Chemistry 
Molecular formula  : C7H4Cl NO2 
Chemical name           :  5-chloro-2-benzoxazolinone. 
Molecular weight          : 169.56 
Chemical Structure         :  
 Description   :    It is a white or almost white crystalline     
                                       powder 
Solubility             :   it is freely soluble in methanol and soluble 
in water and acetonitrile. 
This durg is official in USP / NF – 2006, EP Volume.2 01 /2005ble 
Mechanism of action: 
Chlorzoxazone is a centrally acting muscle relaxant for painful 
musculoskeletal conditions. It acts at the level of the spinal cord and 
subcortical areas of the brain where it inhibits multisynaptic areas 
involved in producing and maintaining skeletal muscle spasm of varied 
etiology. It also possesses sedative property. 
Indication: 
Adjuvant in the treatment of short-term symptomatic treatment of 
painful muscle spasm associated with musculoskeletal conditions. 
Dose:  
Adults: initially 500 mg, t.i.d. or q.i.d. subsequently reduced to 250 mg 
t.i.d./q.i.d. 
PARACETAMOL 
 
Paracetamol is an analgesic and antipyretic agent. 
 
Chemistry: 
Molecular formula  : C8H9NO2 
Molecular weight    : 151.2 
Chemical name       : N-(4-hydroxyphenyl) acetamide. 
Chemical structure :  
 
 
This drug is official in BP -2007 volume –II, USP / NF 2006 and EP 5.0 
Volume 2 01 / 2005. 
Description  : White crystalline powder 
Solubility                : Sparingly soluble in water, freely soluble in 
                                  alcohol, very slightly soluble in methylene chloride.  
 
 
Mechanism of Action:   
Paracetamol exhibits analgesic action by peripheral blockade of 
pain impulse generation. It produces antipyretic effect by inhibiting the 
hypothalamic temperature regulating centre. It’s weak anti-
inflammatory activity is related to inhibition of prostaglandin synthesis 
in the CNS. 
Indication  : Relief of mild to moderate pain & fever  
Dose : Adults 0.5-1g every 4-6 hours Max dose 4g daily 
   Childrens: 6 -12years 250-500mg 4-6hours 
ATORVASTATIN 
Molecular formula  : 2 C33 H34 F N2 O5. Ca 
 
 
 
 
 
 
Chemical Name : (β, R, δR) - 2 (4 fluoro) 
Phenyl, β, δ, dihydroxy - 5.5 - 1 methyl 
ethyl 3 - phenyl - 4 − (phenyl amino) carboxy 1-H - Pyrrole 1 - 
heptonoic acid 
Solubility : Insoluble in aqueous solutions of PH4 and below 
Very slighty soluble in distilled H20. PH 7.4 and acetonitrile 
Mechanism of Action: 
It competitively inhibit HMG - CoA reductase the enzune which 
converts HMG - CoA to mevalonic acid. This is the rate limiting step in 
the biosynthesis of cholesterol. Thus it lowers the LDL level. 
Indication  
 In the treatment of hyper cholestermia 
 
 
 
REVIEW OF LITERATURE 
 
Chatterjee. P.K. et.al (1989) performed the simultaneous 
determination of chlorzoxazone and acetaminophen in combined dosage 
forms by an absorbance ratio technique and difference 
spectrophotometry. 
Pank S.K. et al (1990) carried out the simultaneous 
determination of oxyphenbutazone, chlorzoxazone and paracetamol in 
dosage forms by RP-HPLC. 
El.Kousy et, al (1994) proposed potentiometric & 
spectrocolourimetric methods for the estimation of chlorzoxazone in the 
presence of paracetamol.  
Bhatha.Ms(1995) proposed the simultaneous spectrophotometric 
determination of diclofenac sodium, chlorzoxazone and paracetamol 
from combined dosage forms. 
Sodhi.R.A (1996) carried out the simultaneous determination of 
paracetamol, ibuprofen and chlorzoxazone by HPLC, HPTLC and GLC 
methods  
 
El-Kousy–NM (1999) developed spectrophotometric and 
spectorfluorimetric determination of  etodolac and aceclofenac. 
 
Lec H.S. et.al (2000) carried out simultaneous determination of 
aceclofenac and diclofenac in human plasma by narrowbore HPLC 
using column switching  
 
Rajnarayana K. et.al(2002) validated a HPLC method for 
determination of chlorzoxazone in human serum and it’s application in a 
clinical pharmacokinetic study. 
 
Zawilla –N.H et.al (2002) performed the determination of 
aceclofenac in bulk and pharmaceutical formulations. 
 
El-saharty et.al (2002) proposed stability indicating 
spectrophotometric and densitometric methods for determination of 
aceclofenac. 
Lin–HM. Et.al(2003) carried out HPLC determination of the 
concentration of aceclofenac in human plasma. 
 
Wahbi – AA. Et.al (2003) performed the simultaneous 
determination of paracetamol and chlorzoxazone using orthogonal 
functions ratio spectrophotometry. 
 
Zhang-HS. et.al (2003) reported the simultaneous determination 
of paracetamol and caffeine is fufangan fenwanen capsules by HPLC. 
 
Acuna J.A et.al (2004) studied the polarographic behaviour of 
aceclofenac, Jenoxicam and Droxicam in a methanol –water mixture. 
 
Zinellu A.et.al (2005) carried out the separation of aceclofenac & 
diclofenac in human plasma by free zone capillary electrophoresis using 
Methyl –D- glutamine as an effective electrolyte additive. 
 
 
 
 
 
 
 
 
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
 
 
HPLC has its origin in the early 1960s and was developed based 
on the experience gained from both gas chromatography and column 
chromatography. It was first marketed by Dupont and it then leads to 
rapid development of HPLC as a routine analytical tool.  
The technique of HPLC is based on the same modes of separation 
as column chromatography i.e. adsorption, partition, including reverse 
phase partition, ion-exchange and gel permeation. But this method 
differs from column chromatography by pumping the mobile phase at 
high pressure. The advantages of HPLC are improved resolution of the 
separated substances, faster separation times and the increased accuracy, 
precision and sensitivity with the substances being quantified. 
 
ADSORPTION HPLC: 
It is also generally referred to as normal phase chromatography. 
Normal phase chromatography is based on polar stationary phases. The 
mobile phase consists of a non-polar solvent. 
 
 
REVERSE PHASE HPLC: 
In reverse phase chromatography the stationary phase is prepared 
by chemically bonding a relatively non-polar group onto the stationary 
phase support.  The most frequent non-polar group bonded to the 
stationary support is octadecyl silane (ODS or C18) which gives a 
highly lipophilic  stationary phase. Less lipophilic stationary phases are 
produced when octylsilane (C8), C2, phenyl or cyanopropyl bonded 
stationary phases are used. 
 
The mobile phase in reverse phase HPLC is polar, generally 
consisting of water and water-miscible organic solvent, such as 
methanol or acetonitrile. 
 
Separation in these system is based on different degrees of 
lipophilicity of the solutes; the polar components gets eluted first and 
non-polar components are retained for a longer time. 
Ion-exchange HPLC: 
The ion exchangers in HPLC are generally silica stationary phases 
chemically bonded with anionic or cationic groups, usually 
aminopropyl, tetra-alkyl ammonium or sulphonic acid groups. 
Molecules are generally separated on the basis of their molecular charge 
on the principle of opposite charges attract each other.  Resolution is 
influenced by pH and by ionic strength of the buffer. 
Size exclusion chromatography: 
The separation is based on the size and molecular weight. The 
stationary phase is generally a semi-rigid, porous material in which the 
pore size is selected is selected to be similar to that of solute particles. 
The mobile phase plays no role in the separation, the only requirement 
being that the solutes are soluble in it. 
INSTRUMENT EMPLOYED: 
Chromatographic instrument :  Shimadzu LC-10 AT VP 
Chromatographic column : Phenomenex, Luna 5 micron 
                                                   C18, Size – 250 x 4.60 mm. 
Detector : Shimadzu SPD-10 AVP 
Injection volume : 20 µl 
Syringe : Hamilton 25 µl syringe 
Mode of operation                   : Isocratic 
Temperature                            : Ambient 
Flow-rate : 1.5 ml/min 
Filter membrane                      : Ultipor N66 (nylon 6, 6 membrane) 
                                                  From PALL life sciences. 
Balance                                    : Mettler AB54 
pH meter                                  : Digital pH meter from Md.dalal. 
CHEMICALS: 
Aceclofenac from Paris-Dakner Pharmaceuticals, Chennai. 
Paracetamol from Paris-Dakner Pharmaceuticals, Chennai. 
Chlorzoxazone from Paris-Dakner Pharmaceuticals, Chennai. 
Atorvastatin from Paris-Dakner Pharmaceuticals, Chennai. 
Acetonitrile HPLC grade from E-Merck. 
Methanol HPLC grade from E-Merck. 
Water HPLC grade from E-Merck. 
Ortho-phosphoric analytical grade from Sd fine chemicals 
Disodium hydrogen orthophosphate from sd fine chemicals. 
 
REAGENTS: 
Stock solution: 
Standard stock solutions containing 1mg/ml of aceclofenac, 5 mg/ml of 
chlorzoxazone, and 5 mg/ml of paracetamol are prepared in methanol.  
Preparation of mobile phase: 
Buffer solution: 
Dissolved 3.55 grams of disodium hydrogen ortho phosphate in 
water and made upto 500 ml with water. 
 
Mobile phase: 
Taken 325 ml of acetonitrile and 175 ml of buffer solution and the 
pH was adjusted to 3 with ortho phosphoric acid. The mobile phase is 
then filtered through the Ultipor Nylon 66 membrane. 
 
Establishment of Rt: 
 For determining the Rt values, working standard solutions were 
prepared taking 2 ml of the standard solutions of aceclofenac, 
paracetamol and chlorzoxazone in a series of volumetric flask and made 
up to 10 ml with mobile phase. Diluted 3 ml of these solutions in a 
series of 10 ml of volumetric flask to obtain 60 µg/ml of aceclofenac 
and 300 µg/ml of paracetamol and chlorzoxazone. Injected 20 µl of 
these solutions into the rheodyne injector (272 nm) and the Rt values for 
the paracetamol, aceclofenac and chlorzoxazone are established as given 
below 
 
The retention times are, 
Paracetamol       :  1.85 
Chlorzoxazone   :   3.01 
Aceclofenac       :    3.82 
.  
 Optimization of chromatographic conditions: 
1.  Selection of chromatographic method of separation: 
 Reverse phase chromatography is selected since all the three 
drugs are polar in nature. 
2. Selection of solvent: 
 The drugs exhibited good solubility and stability in methanol. 
Hence methanol was selected as a solvent. 
3.  Selection of detection wavelength: 
 From the overlain spectra 272 was selected as the detection 
wavelength. (Figure No: 1) 
4. Optimization of chromatographic conditions: 
Stationary phase      : Phenomenex C18  column 
Flow rate                 : 1.5 ml per minute 
Operation temperature  : 37• C 
Selected wavelength     : 231 nm. 
a, separation using Methanol and water (75 : 25), pH 4.5; 
The retention times are, 
Paracetamol       :  1.8 
Chlorzoxazone   :   3.01 
Aceclofenac       :    4.15  
b, separation using Methanol and water (75 : 25), pH 3; 
The retention times are, 
Paracetamol       :  1.85 
Chlorzoxazone   :   2.93 
Aceclofenac       :    6.49 
c, separation using Acetonitrile and water (60 : 40), pH 3; 
The retention times are, 
Paracetamol       :  1.6 
Chlorzoxazone   :   2.1 
Aceclofenac       :    3.08 
d, separation using Acetonitrile and water (65 : 35), pH 3; 
The retention times are, 
Paracetamol       :  1.85 
Chlorzoxazone   :   3.01 
Aceclofenac       :    3.82 
Effect of flow rate: 
Peak shapes are better at a flow rate of 1.5 ml per minute than at 1 ml 
per minute. Hence 1.5ml per minute has been selected for further 
studies. 
Optimized chromatographic conditions: 
Stationary phase    :   Phenomenex C18  column 
Solvent ratio          :  Acetonitrile : water (65 : 35) 
pH   :   3 (with disodium hydrogen ortho phosphate buffer) 
Flow rate               :    1.5 ml per minute 
Operation temperature :   37• C 
Selected wavelength    :    231 nm 
Flow rate                      :    1.5 ml per minute. 
Construction of calibration curve: 
 Taken 2 ml of the standard solutions of aceclofenac, 
paracetamol and chlorzoxazone in a volumetric flask and made up to 10 
ml with mobile phase. Varying quantities of this solution (1, 2, 3, 4 and 
5 ml) are diluted with mobile phase in a 10 ml volumetric flask to obtain 
a solution containing 20-100 µg/ml of aceclofenac, 500 µg/ml of 
chlorzoxazone and 500 µg/ml of paracetamol. The concentration of the 
drug was plotted against the area under the curve and shown in Fig 10, 
11, and 12. The values are given in table 1, 2 and 3 respectively. The 
overlain spectrum is given in figure 2. 
Market sample analysis: 
Preparation of sample solution:  
 Weighed twenty tablets of the formulation and were crushed to 
give finely powdered material. Powder equivalent to 25mg of 
Aceclofenac, 125 mg of paracetamol and 125 mg of chlorzoxazone was 
accurately weighed and transferred to a 25ml volumetric flask and were 
dissolved. It is then diluted to the volume using methanol. It was then 
sonicated and filtered. Taken 3 ml of the solution and diluted to 10ml in 
a volumetric flask with methanol. Taken 2ml of the solution and further 
diluted with mobile phase to 10 ml in a volumetric flask. The solution is 
then injected into the rheodyne injector.  The amount of the drug in each 
tablet is  calculated by using the formula given below. 
 Amount of drug in each tablet 
= Area of sample  x  Conc. of standard  x  Dilution factor  x  Average weight 
   Area of standard Weight taken 
 
 The results were furnished in the table 4. The chromatogram is given in  
Figure 3. 
Recovery studies: 
 
It is the measure of the exactness of the analytical method developed 
accuracy can be reported as percent recovery by the assay of analyte in 
the sample. The percent recovery values are given in the table 5. 
  
 
 
 
 
 
 
 
7VALIDATION: 
 
Validation of HPLC method: 
1.  Specificity: 
 The conditions of the HPLC methods like percentage of organic 
solvent in the mobile phase, pH of buffer, flow rate were changed. 
Although the changes were made, no additional peaks were found but 
there were some slight changes in Rf and peak shapes. 
2.  Linearity and range: 
 Varying quantities of mixed stock solutions was diluted with 
mobile phase to give concentrations of 20-100 mcg/ml of Aceclofenac 
and 100-500 mcg/ml of paracetamol and chlorzoxazone. It is then 
injected into the rheodyne injector.  
 Calibration curve was plotted using the peak area of Aceclofenac, 
paracetamol and chlorzoxazone against their corresponding 
concentrations. The drugs exhibited good linearity as evidenced by the 
statistical parameters given in the table 1,2, and 3.graphically it is shown 
in figure 10,11,12. 
3. Accuracy: 
 It is the measure of the exactness of the analytical method 
developed accuracy can be reported as percent recovery by the assay of 
analyte  in  the sample. The percent recovery values are given in the 
table 5. 
4.  Precision; 
 The precision or reproducibility of the determination under the 
optimum condition is determined by conducting the determination of the 
same compound in the freshly prepared stock solution a large number of 
times. The values are given in the table 7. 
 
5.  Limit of detection: 
 It is the lowest concentration of the analyte in a sample that can 
be detected. The values are given in the table 8 
6.  Limit of quantification: 
It is the lowest concentration of an analyte in sample that can be 
determined with acceptable precision and accuracy. The values are 
given in the table 8. 
7.  Ruggedness / robustness: 
 The ruggedness of the analytical method is the degree of 
reproducibility of the test results obtained by the analysis of the same 
samples under a variety of normal test conditions, different analysts, 
different days etc. 
8. System suitability tests: 
 A system suitability test is the integral part of many analytical 
procedures. The tests are based on the concepts of equipment, 
electronics, analytical operations and samples to be analyzed constitute 
an  integral  system  that  can be evaluated as such. It is given in the 
table 9. 
 
 
 
 
 
 
 
 
 
HPLC method using internal standard: 
REAGENTS: 
STOCK SOLUTION: 
Standard stock solutions containing 1mg/ml of aceclofenac, 5 mg/ml of 
chlorzoxazone, 5 mg/ml of paracetamol and 1 mg/ml are prepared in 
methanol.  
Preparation of mobile phase: 
Buffer solution: 
 Dissolved 3.55 grams of disodium hydrogen ortho phosphate in 
water and  made upto 500 ml with water. 
Mobile phase: 
 Taken 325 ml of acetonitrile and 175 ml of buffer solution and the 
pH was adjusted to 3 with ortho phosphoric acid. The mobile 
phase is then filtered through the Ultipor Nylon 66 membrane. 
Establishment of Rt: 
 For determining the Rt values, working standard solutions were 
prepared taking 2 ml of the standard solutions of aceclofenac, 
paracetamol and chlorzoxazone in a series of volumetric flask and made 
up to 10 ml with mobile phase. Diluted 3 ml of these solutions in a 
series of 10 ml of volumetric flask and added 10 µg/ml of atorvastatin to 
obtain 60 µg/ml of aceclofenac and 300 µg/ml of paracetamol and 
chlorzoxazone. Injected 20 µl of these solutions into the rheodyne 
injector and the Rt values for the paracetamol, aceclofenac and 
chlorzoxazone are established as given below 
Paracetamol       :  1.85 
Atorvastatin       :  2.42 
Chlorzoxazone   :   3.01 
Aceclofenac       :    3.82 
 
Optimization of chromatographic conditions: 
1. Selection of chromatographic method of separation: 
Reverse phase chromatography is selected since all the four drugs 
are polar in nature. 
2.  Selection of solvent: 
The drugs exhibited good solubility and stability in methanol. 
Hence methanol was selected as a solvent. 
3.  Selection of detection wavelength: 
From the overlain spectra 272 nm (figure 4) was selected as the 
detection wavelength. 
4.  Optimization of chromatographic conditions: 
Separation using Acetonitrile and water (65 : 35), pH 3; 
The retention times are, 
Paracetamol       :  1.85 
Atorvastatin       :  2.42 
Chlorzoxazone   :   3.01 
Aceclofenac       :    3.82 
Effect of flow rate: 
 Peak shapes are better at a flow rate of 1.5 ml per minute than at 1 
ml per minute. Hence 1ml per minute has been selected for further 
studies. 
Optimized chromatographic conditions: 
Stationary phase     :   Phenomenex C18  column 
Solvent ratio            :  Acetonitrile : water (65 : 35) 
pH                            :   3 (with disodium hydrogen ortho phosphate buffer) 
Flow rate                  :     1.5 ml per minute 
Operation temperature :   37• C 
Selected wavelength    :    272 nm 
Flow rate                      :    1.5 ml per minute. 
Construction of calibration curve: 
 Taken 2 ml of the standard solutions of aceclofenac, 
paracetamol and chlorzoxazone in a volumetric flask and made up to 10 
ml with mobile phase. Varying quantities of this solution (1, 2, 3, 4 and 
5 ml) containing 12 µg/ml of atorvastatin are diluted with mobile phase 
in a 10 ml volumetric flask to obtain a solution containing 20-100 µg/ml 
of aceclofenac, 500 µg/ml of chlorzoxazone and 500 µg/ml of 
paracetamol. The concentration of the drug was plotted against the peak 
area ratio as shown in Fig 13,14, and 15. The values are given in table 
10, 11 and 12. Overlaid spectrum is shown in figure 4. 
Market sample analysis: 
Preparation of sample solution:  
 Weighed twenty tablets of the formulation and were crushed to 
give finely powdered material. Powder equivalent to 25mg of 
Aceclofenac, 125 mg of paracetamol and 125 mg of chlorzoxazone was 
accurately weighed and transferred to a 25ml volumetric flask with 5 ml 
of Atorvastatin stock solution diluted to the volume using methanol. It 
was then sonicated and filtered. Taken 3 ml of the solution and diluted 
to 10ml in a volumetric flask with methanol. Taken 2ml of the solution 
and further diluted with mobile phase to 10 ml in a volumetric flask. The 
solution is then injected into the rheodyne injector. The chromatogram is 
given in figure 6. The amount of the drug in each tablet is calculated by 
using the formula given below. 
 Amount of drug in each tablet 
= Peak area ratio of sample x Conc. of std.  x dil.factor  x   Average weight 
   Peak area ratio of standard Weight taken 
 The results were furnished in the table 13. 
 
Recovery studies: 
It is the measure of the exactness of the analytical method 
developed accuracy can be reported as percent recovery by the assay of 
analyte in the sample. The percent recovery values are given in the 
table14. 
 
VALIDATION: 
 
Validation of HPLC method: 
1.  Specificity: 
The conditions of the HPLC methods like percentage of organic 
solvent in the mobile phase, pH of buffer, flow rate were changed. 
Although the changes were made, no additional peaks were found but 
there were some slight changes in Rf and peak shapes. 
2. Linearity and range: 
Varying quantities of mixed stock solutions was diluted with 
mobile phase to give concentrations of 20-100 mcg/ml of Aceclofenac 
and 100-500 mcg/ml of paracetamol and chlorzoxazone. It is then 
injected into the rheodyne injector.  
Calibration curve was plotted using the peak area ratios of 
aceclofenac, paracetamol and chlorzoxazone against their corresponding 
concentrations. The drugs exhibit good linearity in the said range as 
evidenced by the correlation coefficients given in the table 15. The 
statistical parameters are given in table 15. 
 3. Accuracy: 
It is the measure of the exactness of the analytical method 
developed accuracy can be reported as percent recovery by the assay of 
analyte in the sample. The percent recovery values are given in the table 
14. 
4.  Precision; 
 The precision or reproducibility of the determination under the 
optimum condition is determined by conducting the determination of the 
same compound in the freshly prepared stock solution a large number of 
times. The values are given in the table 16. 
5.  Limit of detection: 
It is the lowest concentration of the analyte in a sample that can 
be detected. The values are given in the table17 
6.  Limit of detection and quantification: 
 It is the lowest concentration of an analyte in sample that can be 
determined with acceptable precision and accuracy. The values are 
given in the table 17. 
7.  Ruggedness / robustness: 
 The ruggedness of the analytical method is the degree of 
reproducibility of the test results obtained by the analysis of the same 
samples under a variety of normal test conditions, different analysts, 
different days etc. 
8,  System suitability tests: 
 A system suitability test is the integral part of many analytical 
procedures. The tests are based on the concepts of equipment, 
electronics, analytical operations and samples to be analyzed constitute 
an  integral  system   that  can  be   evaluated  as   such. It is given in the 
table 18. 
 
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY: 
High performance thin layer chromatography involves the 
equilibration of a compound between a mobile phase and a thin 
stationary phase bound to a flat plate. The smaller particle size 
compared to the thin layer chromatography results in the better 
resolution. 
HPTLC techniques involve the normal phase or reverse phase 
separation. Normal phase HPTLC is done with precoated unmodified 
silica gel plates and the reverse phase HPTLC with chemically modified 
RP-2, RP-8, and RP-18 silica gel plates. In the present work normal 
phase HPTLC separation was done with precoated unmodified silica gel 
plates. 
Most of the drugs in the formulation can be analyzed by HPTLC 
method because of the advantages like rapidity, specificity, accuracy 
and precision. HPTLC method eliminates tedious extraction and 
isolation procedures. 
 
 
 
INSTRUMENTS USED: 
CAMAG LINOMAT IV (Schimadzu dual wavelength scanner) 
Plate material : HPTLC Silica (merck) 
Application mode : CAMAG Sample applicator. 
Application chamber : CAMAG twin through glass chamber. 
Hamilton syringe – 25 µl 
CAMAG TLC Scanner version 3.20 
CHEMICALS AND REAGENTS: 
Toluene: analytical grade from E-Merck. 
Ethyl acetate: analytical grade from E-Merck. 
Glacial acetic acid: HPLC grade from E-Merck. 
Chloroform: HPLC grade from E-Merck 
Methanol: HPLC grade from E-Merck. 
Ammonia: analytical grade from qualigens. 
MOBILE PHASE: 
The mobile phase is prepared by mixing 35 ml of methanol with 10 ml 
of ethyl acetate and then 1 ml of glacial acetic acid is added to get the 
required mobile phase. 
PREPARATION OF STOCK SOLUTIONS:  
                 Standard stock solutions of Aceclofenac (1mg,/ml), 
Paracetamol (5mg/ml) and chlorzoxazone (5mg/ml) were prepared in 
methanol. 
ESTABLISHMENT OF Rf VALUES: 
For determining the Rf values, working standard solutions were prepared 
by diluting 3 ml of aceclofenac, paracetamol and chlorzoxazone from 
the stock solution to a series of 10ml volumetric flasks and making up 
the volume with methanol. Spotted 15 µl of the solution on the TLC 
plates and the Rf values for the paracetamol, aceclofenac and 
chlorzoxazone are established. 
The Rf values are 
Paracetamol  = 0.12 
Aceclofenac  = 0.29 
Chlorzoxazone = 0.72 
OPTIMIZATION OF CHROMATOGRAPHIC CONDITIONS: 
a) Separation using CHCl3+ CH3OH + NH3 (48:11:05.): 
The Rf values are 
Chlorzoxazone -    0.9 
Aceclofenac     -    0.62 
Paracetamol     -    0.60 
b)  Separation using Toluene + ethyl acetate + glacial acetic acid 
 (15+10+0.05): 
The Rf values are 
Paracetamol           - 0.17 
Aceclofenac              -  0.3  
Chlorzoxazone            - 0.7 
c) Separation using Tolune +ethyl acetete + glacial acetic acid  
                                                                    (15 + 10 + 0.2): 
The Rf values are 
Paracetamol  = 0.19 
Aceclofenac  = 0.30 
Chlorzoxazone = 0.72 
d) Separation using Toluene +ethyl acetate + glacial acetic acid 
                                                                            (17.5 +10+0.5): 
The Rf values are 
Paracetamol  = 0.12 
Aceclofenac  = 0.29 
Chlorzoxazone = 0.72 
OPTIMIZED CHROMATOGRAPHIC CONDITION: 
Stationary phase     : Silicagel Gf 254 
Mobile Phase  : Toluene + ethyl acetate + glacial acetic acid    
                                   (17.5 + 10 +0.5)                                                                                
Lamp                     :  Deuterium 
Wavelength           : 272 nm 
Migration distance  : 70 mm  
Band with               :  3 mm 
Distance between the tracks: 10 mm 
Rf values : 
Paracetamol  = 0.12 
Aceclofenac  = 0.29 
Chlorzoxazone = 0.72 
CONSTRUCTION OF CALIBRATION CURVE: 
Weighed 25mg of Aceclofenac, 125 mg of paracetamol and 125 
mg of chlorzoxazone and were dissolved in methanol and made up the 
volume to 25ml in a volumetric flask. A series of dilution is then made 
by diluting 1, 2, 3, 4 and 5 ml of the solution in a 10ml standard flask. 
The concentration range for aceclofenac, paracetamol and 
chlorzoxazone was 0.1-0.5mg/ml, 0.5-2.5 mg /ml and 0.5-2.5mg /ml 
respectively. The solution is then spotted (15 µl) on the TLC plates by 
using automatic application device. The chromatographic plate is then 
developed in a saturated twin through chamber containing the mobile 
phase. After development the plates were scanned at 293 nm and the 
peak areas were measured and given in the Table No 19, 20, and 21. 
Calibration curve was constructed by plotting concentration against peak 
areas as shown in Fig 16,17 and 18. The chromatogram is given in 
figure 7. 
MARKET SAMPLE ANALYSIS: 
Weighed twenty tablets of the formulation and were crushed to 
give finely powdered material. Powder equivalent to 25mg of 
Aceclofenac, 125 mg of paracetamol and 125 mg of chlorzoxazone was 
accurately weighed and transferred to a 25ml volumetric flask and were 
dissolved. It is then diluted to the volume using methanol. It was then 
sonicated and filtered. Taken 3 ml of the solution and diluted to 10ml in 
a volumetric flask with methanol. Spotted 15 µl/ml of standard and 
sample in the precoated TLC plate using automatic application device. 
The chromatographic plate was developed in a twin through chamber 
containing the mobile phase. After development the well resolved bands 
of the drug were scanned at 231 nm. The amount of aceclofenac, 
paracetamol and chlorzoxazone present in the tablet is calculated by the 
formula given below. 
Amount of drug in each tablet 
= Area of sample  x  Conc. of standard  x  Dilution factor  x  Average weight 
   Area of standard Weight taken 
The amount present in each tablet is given in the table 22. The 
chromatogram is given in figure 8. 
RECOVERY STUDY: 
The accuracy of an analytical method is the test results obtained 
by the method to the true value. Accuracy may often be expressed as 
percent recovery by the assay in which a known amount of analyte was 
added. 
 It is calculated by the formula. 
Percentage recovery = N∑xy –(∑x∑y) 
                        N ∑x2-(∑x)2 
X = Amount of drug added in mg/g 
N = Total no. of observations 
The Percentage Recovery is given in the Table No: 23 
VALIDATION: 
The developed analytical method was validated for 
i)   Specificity: 
For demonstrating specificity, the conditions of the HPTLC 
method developed namely the percentage of the organic solvent in the 
mobile phase, volume etc. was changed and no additional peaks were 
observed. 
ii)   Linearity and Range: 
 The linearity of an analytical method is its ability to elicit test 
results that are directly proportional to the concentration of the analyte 
in sample within a given range. 
 The linearity of an analytical method is determined by a 
mathematical treatment of test results obtained by the analysis of 
samples with analyte concentration across the claimed range of the 
method. 
It is done usually through the construction of regression line and 
calculating its slope and intercept which is given in table 24. Alternatively it 
cane be done graphically by plotting the test results as a function of 
analyte concentration which is shown in the figure 15, 16 and 17. 
iii)  Accuracy: 
 The accuracy of an analytical method is the test results obtained 
by the method to the true value. Accuracy may often be expressed as 
percent recovery by the assay in which a known amount of analyte was 
added. 
 It is calculated by the formula. 
Percentage recovery = N∑xy –(∑x∑y) 
                        N ∑x2-(∑x)2 
X = Amount of drug added in mg/g 
N = Total no. of observations 
 The Percentage Recovery is given in the table 23. 
iv)  Precision; 
 The precision or reproducibility of the analytical method is 
determined by assaying a sufficient number of test solutions of the same 
compound and calculating its standard deviation and relative standard 
deviation. 
The S.D is calculated by the formula 
S.D = ∑(X-x)2 
           N -1  
Where X = ∑x 
          N 
(X-x) = derivation from mean. 
C.V = 100 x  S % 
            X. 
The intra day precision is given in the table 25. 
v)  Limit of Quantification: 
 It is the lowest concentration of an analyte in a sample that can be 
determined with acceptable precision and accuracy under the stated 
experimental conditions. The values are given in table 26. 
vi)  Limit of Quantification: 
 It is the lowest concentration of an analyte in a sample detected 
under  the stated  experimental  conditions.  The values are given in 
table 26 
vii)  Ruggedness / Robustness: 
 Ruggedness is a measure of reproducibility of test results under 
normal, expected operational conditions from laboratory to laboratory 
and from analyst to analyst. 
viii)  System suitability tests: 
 System suitability tests ensure that the method developed can 
generate results of acceptable accuracy and precision and values are 
given in table 27. 
DIFFERENTIAL SPECTROSCOPY 
 
 
Difference spectrophotometric assay is based on the principle in 
which the measured value of difference absorbance Δ A between two 
equimolar solutions of the analyte in different chemical forms exhibit 
different spectral characteristics. 
 
          The selectivity and accuracy of spectrometric assay of sample 
containing absorbing interferents may be improved by the technique of 
difference spectrophotometry. 
Criteria for difference spectroscopy: 
i. Reproducible changes may be induced in the spectrum of the 
analyte by the addition of one (or) more reagents. 
ii. The absorbance of the interfering substance is not changed by 
 the reagents.  
         Difference spectrophotometry is simplest and most commonly 
employed technique for altering the spectral properties of the analyte. It 
is done by adjusting the pH by means of aqueous solutions of acid, 
alkali (or) buffers. 
          The UV –visible absorption spectra of the substance containing 
lonisable functional groups will depend upon the state of ionization of 
the functional group and consequently the pH of the solution. Examples 
of such functional groups include phenols, aromatic carboxylic acids 
and amines 
          If the individual absorbance, Aalk and Aacid are proportional to the 
concentration of the analyte and pathlength , then ΔA also obeys the 
Beer-Lambert Law and a modified equation may be derived. 
                                     Δ A =Δabc 
             ΔA is the difference absorptivity of the substance at the wave 
length of measurement.                      
INSTRUMENT EMPLOYED: 
 
Schimadzu UV-1650 PC UV/VIS Spectrophotometer. 
Mettler AB54 balance 
Chemicals and reagents: 
 
Methanol analytical grade (E-Merck) 
Sodium hydroxide 0.1M 
Dissolved 2g of sodium hydroxide in distilled water and made up to 500 
ml to obtain 0.1M sodium hydroxide. 
 
 
 
Hydrochloric acid 0.1M: 
 Mixed 1.825 ml of 1M hydrochloric acid in distilled water and 
made upto 500 ml. 
PREPARATION OF STANDARD STOCK SOLUTION: 
 Dissolved 30mg of aceclofenac in methanol and made up the 
volume to 25 ml in a volumetric flask to obtain a standard stock solution 
containing 1.2 mg/ml of aceclofenac. 
Experiment: 
Establishment of absorbtion maximum: 
 The standard stock solution was suitably diluted to give the 
concentration of 0.45 µg/ml. The dilutions are made with 0.1M 
hydrochloric acid and 0.1M sodium hydroxide in two separate 
volumetric flasks. The solutions are then scanned in the UV region (200-
400nm) keeping the corresponding reagent blank. The λmax for acidic 
(0.1M hydrochloric acid) and alkaline (0.1M sodium hydroxide) 
solutions were observed at 272 nm and 218 nm respectively.It is shown 
in the figure 9. 
Construction of calibration graph: 
 The standard stock solution was suitably diluted to give the 
concentration of 0.96 µg/ml to 96 µg/ml of aceclofenac. The dilutions 
were made separately using 0.1M sodium hydroxide and 0.1M 
hydrochloric acid. The absorbances were then measured 272 nm for 
both acidic and alkaline solutions of the drug and the difference 
absorbance (ΔA) is plotted against the concentration. (Figure 19) and 
the data were given in shown in the table 28. 
Market sample analysis:  
 The average weight of twenty tablets were determined and ground 
to a fine powder. An accurately weighed sample equivalent to 30 mg of 
aceclofenac was transferred to a 25 ml volumetric flask. It was shaken 
with 20 ml of methanol, sonicated and made up to the volume  with 
methanol. The solution was then filtered through the Whatmann filter 
No.1. The solution was then diluted with 0.1M hydrochloric acid and 
0.1M sodium hydroxide in two separate volumetric flask to obtain the 
concentration of 0.54 µg/ml.  
Amount of aceclofenac present in each tablet is calculated using the 
formula mentioned below, 
Amount of drug in each tablet 
= ΔA of sample  x  Conc. of standard  x  Dilution factor  x  Average weight 
   ΔA of standard Weight taken 
 
The results were given in table 29. 
Recovery study: 
To ensure the accuracy and reproducibility of the above method, 
recovery studies were carried out by adding a known quantity of 
standard drug with the pre analyzed sample formulation and the 
percentage recovery was calculated. The values are given in the table 30. 
Validation: 
Validation of differential spectroscopic method: 
1.  Specificity: 
The conditions of the differential spectroscopic methods like pH 
of hydrochloric acid and sodium hydroxide were changed. Although the 
changes were made, there is no change in the λmax. 
2.  Linearity and range: 
 Varying quantities of stock solutions was diluted with methanol to 
give concentrations of 9.6 to 96 µg/ml of aceclofenac. The absorption  
was then measured in the UV spectrophotometer. Table 33 shows the 
statistical data obtained. The calibration graph was found to be linear in 
the concentration range of 9.6 to 96 µg/ml with the correlation 
coefficient of 0.9997. The results indicated good linear relationship 
between peak area and concentration. 
 
 
3.  Accuracy: 
 It is the measure of the exactness of the analytical method 
developed accuracy can be reported as percent recovery by the assay of 
analyte in the sample. The percent recovery values are given in the  
table 30. 
4.  Precision; 
 The precision or reproducibility of the determination under the 
optimum condition is determined by conducting the determination of the 
same compound in the freshly prepared stock solution a large number of 
times. The values are given in the table. The results in table 31 indicate 
that the method is highly precise. 
5.  Limit of detection: 
 It is the lowest concentration of the analyte in a sample that can 
be detected. The values are given in the table 32. 
6.  Limit of quantification: 
 It is the lowest concentration of an analyte in sample that can be 
determined with acceptable precision and accuracy. The values are 
given in the table 32. 
7.  Ruggedness / robustness: 
 The ruggedness of the analytical method is the degree of 
reproducibility of the test results obtained by the analysis of the same 
samples under a variety of normal test conditions, different analysts, 
different days etc 
 
Figure No: 1 
 
Overlaid spectrum of aceclofenac, paracetamol and chlorzoxazone. 
 
 
 
 
 
 
 
 
Figure No: 4 
 
Overlaid spectrum of aceclofenac, paracetamol, chlorzoxazone and 
atorvastatin. 
 
 
 
 
 
 
 
 
Figure No: 16 
 
Calibration graph of aceclofenac (HPTLC) 
 
 
 
 
 
 
 
 
 
 
Figure No: 17 
 
Calibration graph of paracetamol (HPTLC) 
 
 
 
 
 
 
 
 
 
 
Figure No: 18 
 
Calibration graph of chlorzoxazone (HPTLC) 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 10 
 
Calibration graph of aceclofenac (HPLC) 
 
 
 
 
 
 
 
 
 
Figure No: 12 
 
Calibration graph of chlorzoxazone (HPLC) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 11 
 
Calibration graph of paracetamol (HPLC) 
 
 
 
 
 
 
 
 
 
 
 
Figure No:13 
 
Calibration graph of aceclofenac ( HPLC with internal standard) 
 
 
 
 
 
 
 
 
 
Figure No: 14 
 
Calibration graph of paracetamol (HPLC with internal standard) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 15 
 
Calibration graph of chlorzoxazone (HPLC with internal standard) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 19 
 
Calibration graph of aceclofenac (difference spectroscopy) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 6 
 
 Sample chromatogram of aceclofenac, paracetamol and chlorzoxazone 
with internal standard Atorvastatin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 8 
 
Sample chromatogram of aceclofenac, paracetamol and chlorzoxazone 
(HPTLC) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 2 
 
Standard chromatogram of aceclofenac, paracetamol and chlorzoxazone  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 7 
 
Standard chromatogram of aceclofenac, paracetamol and chlorzoxazone 
(HPTLC) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 5 
 
Standard chromatogram (overlaid) of aceclofenac, paracetamol and 
chlorzoxazone with internal standard Atorvastatin (HPLC) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 3 
 
Sample chromatogram of aceclofenac, paracetamol and chlorzoxazone 
 
 
 
 
 
 
Figure No: 9 
 
Over laid spectra of Aceclofenac in Hcl & NaoH 
 
 
 
TABLE NO: 1. 
 
Linearity and range of aceclofenac  
 
S.No. Concentration of aceclofenac in µg/ml Peak area 
1 20 34.6821 
2 40 66.1284 
3 60 105.3279 
4 80 135.0819 
5 100 171.4160 
TABLE NO : 2 
 
Linearity and range of chlorzoxazone  
 
S.No. Concentration chlorzoxazone in µg/ml Peak area 
1 100 187.8214 
2 200 379.9018 
3 300 573.5491 
4 400 760.1906 
5 500 944.3217 
TABLE NO: 3 
 
Linearity and range of paracetamol  
 
S.No. Concentration paracetamol in µg/ml Peak area 
1 100 212.9615 
2 200 430.6160 
3 300 653.2281 
4 400 853.1782 
5 500 1058.6270 
 
 TABLE NO: 19. 
 
Linearity and range of aceclofenac (HPTLC) 
 
S.No. Concentration aceclofenac in mg/ml Peak area 
1 0.1 41.3 
2 0.2 80.5 
3 0.3 126.7 
4 0.4 161.3 
5 0.5 200.4 
 
TABLE NO: 20 
 
Linearity and range of paracetamol (HPTLC) 
 
 
S.No. Concentration paracetamol in mg/ml Peak area 
1 0.5 111.3 
2 1.0 220.8 
3 1.5 331.6 
4 2.0 460.1 
5 2.5 563.9 
 
TABLE NO: 21 
 
Linearity and range of chlorzoxazone (HPTLC) 
 
S.No. Concentration chlorzoxazone in mg/ml Peak area 
1 0.5 62.2 
2 1.0 122.5 
3 1.5 187.7 
4 2.0 243.6 
5 2.5 305.9 
 
TABLE NO: 22 
 
Estimation of aceclofenac, paracetamol and chlorzoxazone (HPTLC) 
 
S.No Name of the drug 
Label 
claim 
(mg/tablet)
Amount 
found 
(mg/tablet) 
standard 
deviation 
Relative 
standard 
deviation
 
1 
 
2 
 
3 
 
 
 
 
Aceclofenac 
 
 
100 
 
100 
 
100 
 
102.1286 
 
101.8918 
 
101.1025 
 
 
 
0.537229 
 
 
 
0.52820 
 
1 
 
2 
 
3 
 
 
 
 
 
Paracetamol 
 
 
500 
 
500 
 
500 
 
501.9841 
 
502.702 
 
503.3051 
 
 
 
0.679907 
 
 
 
0.13526 
 
1 
 
2 
 
3 
 
 
 
 
         
chlorzoxazone 
 
500 
 
500 
 
500 
 
495.9923 
 
495.7259 
 
497.0578 
 
 
 
0.704765 
 
 
 
0.14201 
 
 
 
 
 
 
 
 
 
TABLE NO : 23 
 
Recovery of aceclofenac, paracetamol and chlorzoxazone (HPTLC) 
 
S.No Drug 
Amount 
of drug 
in 
sample 
(mg) 
Amount 
of drug 
added 
(mg) 
Amount 
Recovered 
(mg) 
Percent 
Recovery 
 
1 
 
2 
 
3 
 
 
 
 
Aceclofenac 
 
102.1286
 
101.8918
 
101.1025
 
10 
 
10 
 
10 
 
9.8655 
 
9.9445 
 
10.0234 
 
       
 
98.6587 
 
99.4451 
 
100.2344 
 
1 
 
2 
 
3 
 
 
 
 
Paracetamol 
 
501.9481
 
502.702 
 
503.3051
 
50 
 
50 
 
50 
 
49.6067 
 
49.7575 
 
49.9083 
 
99.2135 
 
99.5150 
 
99.8166 
 
1 
 
2 
 
3 
 
 
 
 
Chlorzoxazone 
 
495.992 
 
495.7529
 
497.0578
 
50 
 
50 
 
50 
 
49.5459 
 
50.0787 
 
49.5459 
 
99.0919 
 
100.1574 
 
99.0919 
 
 
 
TABLE No : 24 
 
Statistical parameters in HPTLC 
 
 
S.No 
 
Parameter 
 
Aceclofenac
 
Paracetamol
 
Chlorzoxazone
1 Regression equation 
(y) 
349.7 x 
-0.009 
228.62 x – 
5.530 
121.7 x -
0.01504 
2 Slope (m) 349.7 228.62 121.7 
3 Intercept (b) -0.009 -5.530 -0.01504 
4 Correlation 
coefficient(r) 
0.9979 0.9991 0.9996 
 
TABLE NO : 25 
 
Precision data for aceclofenac, paracetamol and chlorzoxazone 
(HPTLC) 
 
   
S.No Drug 
Conc. of the 
drug in 
mg/ml 
Peak area 
Standard 
deviation 
 
C.V. 
 
 
 
 
1 
 
 
 
 
  
Aceclofenac 
 
 
 
 
0.3 
 
125.4 
125.8 
126.5 
126.1 
126.7 
127.6 
127.5 
127.6 
 
 
 
 
  
 0.8569 
 
 
 
 
0.6769 
 
 
 
 
2 
 
 
 
 
 
 
Paracetamol 
 
 
 
 
1.5 
 
330.7 
330.8 
331.4 
330.8 
331.6 
331.7 
332.4 
333.2 
 
 
 
 
0.8730 
 
 
 
 
0.2632 
 
 
 
 
3 
 
 
 
 
 
 Chlorzoxazone
 
 
 
 
1.5 
 
186.3 
187.4 
187.2 
187.6 
186.9 
188.2 
188.9 
188.1 
 
 
 
 
 0.8172 
 
 
 
 
 0.4356
TABLE NO : 26 
 
LOD and LOQ (HPTLC) 
 
S.No Parameter Aceclofenac Paracetamol Chlorzoxazone 
1 LOD 4µg/ml 8 µg/ml 17 µg/ml 
2 LOQ 15 µg/ml 29 µg/ml 57µg/ml 
 
TABLE No : 27 
System Suitability Parameters (HPTLC) 
 
S.No Parameter Paracetamol aceclofenac chlorzoxazone
1 Rf .12 .29 .72 
2 Asymmetry factor 1.07 1.02 1.12 
3 Theoretical 
plates/meter 
962 1956 4365 
4 Linearity 0.5-
2.5mg/ml 
0.1-
0.5mg/ml 
0.5-2.5mg/ml 
 
TABLE No : 28 
Linearity of  Aceclofenac (Differential Spectormetry) 
TABLE No: 29 
Estimation of Aceclofenac by UV spectrometry (Diferential 
Spectroscopy) 
 
S.No Name of the drug 
Label claim 
(mg/tablet) 
Amount 
found 
(mg/tablet)
standard 
deviation 
 
Relative 
standard 
deviation
 
 
1 
 
2 
 
3 
 
 
 
 
Aceclofenac 
 
 
100 
 
100 
 
100 
 
101.3036 
 
101.6294 
 
100.9779 
 
 
 
0.3257 
 
 
 
0.3215 
 
S.No Concentration of Aceclofenac in µg/ml Absorbance 
1 9.6 0.061 
2 19.2 0.127 
3 28.8 0.186 
4 38.4 0.246 
5 48.0 0.307 
6 57.6 0.357 
7 67.2 0.426 
8 76.8 0.486 
9 86.4 0.553 
10 96.0 0.612 
TABLE - 30 
Recovery of Aceclofenac (differential spectrometry) 
 
S.No Drug 
Amount 
of drug 
in 
sample 
(mg) 
Amount 
of drug 
added 
(mg) 
Amount 
Recovered 
(mg) 
Percent 
Recovery 
 
1 
 
2 
 
 
 
 
Aceclofenac 
 
 
 
 
101.3036
 
100.9779
 
 
 
10 
 
10 
 
 
 
10.0978 
 
9.7720 
 
       
 
100.9780 
 
97.7206 
 
 
TABLE - 31 
Precision data for Aceclofenac 
 
 
S.No Drug 
Conc. of 
the drug in 
µg/ml 
absorbance
Standard 
deviation 
 
C.V. 
 
 
 
 
1 
 
 
 
  
Aceclofenac 
 
 
 
 
48.7 
0.311 
0.312 
0.312 
0.309 
0.313 
0.315 
0.313 
0.312 
 
 
 
  
 .0017 
 
 
 
 
.5532 
Table -  32 
LOD and LOQ (difference spectrometry) 
 
S.No Parameter Aceclofenac 
1 LOD 6 ng/ml 
2 LOQ 20 ng/ml 
 
Table - 5 
Recovery of Aceclofenac, Chlorzoxazone & Paracetomal (HPLC) 
 
S.No Drug 
Amount of 
drug in 
sample 
(mg) 
Amount 
of drug 
added 
(mg) 
Amount 
Recovered 
(mg) 
Percent 
Recovery 
 
1 
 
2 
 
3 
 
 
 
 
Aceclofenac 
 
101.0852 
 
100.3345 
 
101.335 
 
10 
 
10 
 
10 
 
9.9537 
 
10.09408 
 
9.9013 
 
99.537 
 
100.9408 
 
99.01351 
 
1 
 
2 
 
3 
 
 
 
 
Paracetamol 
 
502.3227 
 
501.1098 
 
501.1222 
 
50 
 
50 
 
50 
 
50.0827 
 
50.7578 
 
50.1470 
 
100.1654 
 
101.5157 
 
100.294 
 
1 
 
2 
 
3 
 
 
 
 
Chlorzoxazone 
 
496.1929 
 
496.6073 
 
498.3508 
 
50 
 
50 
 
50 
 
50.0765 
 
49.8977 
 
50.1026 
 
100.153 
 
99.7954 
 
100.2053 
 
  
TABLE - 33 
Statistical Parameters for Aceclofenac 
 
 
S.No 
 
Parameter 
 
Aceclofenac 
 
1 
 
 
Regression equation (y) 
 
157.83 x – 0.2492 
 
2 
 
 
Slope (m) 
 
157.83 
 
3 
 
 
Intercept (b) 
 
-0.2492 
 
4 
 
 
Correlation coefficient(r) 
 
0.9997 
TABLE NO: 4 
Estimation of aceclofenac, paracetamol and chlorzoxazone (HPLC) 
 
 
S.No 
 
Name of the 
drug 
 
Label 
claim 
(mg/tablet)
 
Amount 
found 
(mg/tablet)
 
standard 
deviation 
 
Relative 
standard 
deviation
 
 
1 
 
2 
 
3 
 
 
 
 
Aceclofenac 
 
 
100 
 
100 
 
100 
 
101.0852 
 
100.3345 
 
101.335 
 
 
 
0.528793 
 
 
 
0.52394 
 
1 
 
2 
 
3 
 
 
 
Paracetamol 
 
 
500 
 
500 
 
500 
 
502.24 
 
501.1098 
 
501.1222 
 
 
 
0.648932 
 
 
 
0.12940 
 
1 
 
2 
 
3 
 
 
 
         
chlorzoxazone 
 
500 
 
500 
 
500 
 
496.1929 
 
496.6073 
 
497.479 
 
 
 
0.656455 
 
 
 
0.13214 
 
TABLE No: 6 
Statistical parameters in HPLC 
 
S.No Parameter Aceclofenac Paracetamol Chlorzoxazone
1 Regression 
equation (y) 
1.712 x + 
0.1163 
2.114 x – 
1.871 
1.894 x -
0.3895 
2 Slope (m) 1.712 2.114 1.894 
3 Intercept (b) 0.1163 -1.871 -0.3895 
4 Correlation 
coefficient(r) 
0.993 0.9999 0.9999 
 
Table No: 7 
 
Precision data for aceclofenac, paracetamol and chlorzoxazone (HPLC) 
 
 
 
S.No Drug 
Conc. Of 
the drug in 
µg/ml 
Peak 
area 
Standard 
deviation 
 
C.V. 
 
 
 
 
1 
 
 
 
 
  
Aceclofenac 
 
 
 
 
60 
 
104.9736
104.67 
105.0826
104.3405
105.5732
105.9858
105.6822
106.3153
 
 
 
 
  
 0.67474 
 
 
 
 
0.6406 
 
 
 
 
   2 
 
 
 
 
 
 
 
Paracetamol 
 
 
 
 
300 
 
634.2738
634.5702
634.9828
634.2407
635.4734
635.886 
636.0824
636.2155
 
 
 
 
 
0.8084 
 
 
 
 
0.1272 
 
 
 
 
3 
 
 
 
 
 
 
 
 Chlorzoxazone 
 
 
 
 
300 
 
573.1948
572.5612
573.3038
572.5617
573.7944
574.537 
573.9034
574.5365
 
 
 
 
 0.78131 
 
 
 
 
 0.1362
Table No: 8 
 
LOD and LOQ (HPLC) 
 
S.No Parameter Aceclofenac Paracetamol Chlorzoxazone
1 LOD 0.9 µg/ml 0.9 µg/ml 1.81 µg/ml 
2 LOQ 3.0 µg/ml 3.06 µg/ml 6.0µg/ml 
 
Table No: 9 
 
System suitability parameters (HPLC) 
 
S.No Parameter Paracetamol Chlorzoxazone Aceclofenac
1 Capacity factor 1.5 2.1 3.09 
2 Asymmetry factor 1.09 1.12 1.16 
3 Theoretical 
plates/meter 
24648 69662 76659 
4 Linearity 100-500 
µg/ml 
100-500 µg/ml 20-100 
µg/ml 
 
TABLE NO: 10. 
 
Linearity and range of aceclofenac (HPLC with internal standard) 
 
S.No. Concentration of aceclofenac in µg/ml Peak area ratio 
1 20 0.0668 
2 40 0.1275 
3 60 0.2031 
4 80 0.2604 
5 100 0.3305 
TABLE NO : 11 
 
Linearity and range of chlorzoxazone (HPLC with internal standard) 
 
S.No. Concentration chlorzoxazone in µg/ml Peak area ratio 
1 100 0.3621 
2 200 0.7325 
3 300 1.1060 
4 400 1.4659 
5 500 1.8210 
TABLE NO: 12 
 
Linearity and range of paracetamol (HPLC with internal standard) 
 
S.No. Concentration paracetamol in µg/ml Peak area ratio 
1 100 0.4106 
2 200 0.8302 
3 300 1.2596 
4 400 1.6452 
5 500 2.0414 
TABLE NO: 13 
 
Estimation of aceclofenac, paracetamol and chlorzoxazone                     
(HPLC with internal standard) 
 
S.No Name of the drug 
Label 
claim 
(mg/tablet)
Amount 
found 
(mg/tablet)
standard 
deviation 
 
Relative 
standard 
deviation
 
 
1 
 
2 
 
3 
 
 
 
 
Aceclofenac 
 
 
100 
 
100 
 
100 
 
99.8985 
 
100.7355 
 
101.0801 
 
 
 
0.6076 
 
 
 
0.6042 
 
1 
 
2 
 
3 
 
 
 
 
 
Paracetamol 
 
 
500 
 
500 
 
500 
 
501.3742 
 
500.104 
 
499.7071 
 
 
 
0.8708 
 
 
 
0.1740 
 
1 
 
2 
 
3 
 
 
 
 
         
chlorzoxazone 
 
500 
 
500 
 
500 
 
496.8205 
 
497.0013 
 
498.1767 
 
 
 
0.7363 
 
 
 
0.1480 
 
TABLE NO:14 
 
Recovery of aceclofenac, paracetamol and chlorzoxazone                     
(HPLC with internal standard) 
 
S.No Drug 
Amount 
of drug 
in 
sample 
(mg) 
Amount 
of drug 
added 
(mg) 
Amount 
Recovered 
(mg) 
Percent 
Recovery 
 
 
 
1 
 
 
 
Aceclofenac 
 
99.8985 
 
100.7355
 
101.0801
 
10 
 
10 
 
10 
 
9.8963 
 
9.9947 
 
9.9455 
 
       
 
99.96304 
 
99.9477 
 
99.4554 
 
 
 
2 
 
 
 
 
Paracetamol 
 
501.3742
 
500.104 
 
499.7071
 
50 
 
50 
 
50 
 
50.4113 
 
50.2922 
 
49.9349 
 
100.8226 
 
100.5845 
 
99.8699 
 
 
3 
 
 
 
 
 
Chlorzoxazone 
 
496.8205
 
497.0013
 
498.1767
 
50 
 
50 
 
50 
 
49.814 
 
50.0143 
 
50.2463 
 
99.628 
 
100.0287 
 
100.4927 
 
Table No: 16 
 
Statistical parameters in HPLC (with internal standard) 
 
S.No Parameter Aceclofenac Paracetamol Chlorzoxazone
1 Regression equation 
(y) 
0.0033 x -
0.0003 
0.0040 x + 
0.145 
0.0036 x + 
0.0022 
2 Slope (m) 0.0033 0.0040 0.0036 
3 Intercept (b) -0.0003 0.0145 0.0022 
4 Correlation 
coefficient(r) 
0.9993 0.9997 0.9999 
 
Table No: 15 
 
Precision data for aceclofenac, paracetamol and chlorzoxazone            
(HPLC with internal standard) 
 
 
 
S.No Drug 
Conc. Of 
the drug in 
µg/ml 
Peak 
area 
Standard 
deviation 
 
C.V. 
 
 
1 
 
2 
 
3 
 
 
 
 
  
Aceclofenac 
 
 
 
 
60 
 
0.2028 
0.2049 
0.2044 
0.2058 
0.2035 
0.2039 
0.2068 
0.2047 
 
 
 
 
  
 0.0012 
 
 
 
 
0.6226 
 
 
    1 
 
2 
 
3 
 
 
 
 
 
Paracetamol 
 
 
 
 
300 
 
1.2614 
1.2601 
1.2567 
1.2601 
1.2604 
1.2599 
1.2610 
1.2608 
 
 
 
 
0.0015 
 
 
 
 
0.1212 
 
 
1 
 
2 
 
3 
 
 
 
 
 
 Chlorzoxazone 
 
 
 
 
300 
 
1.1057 
1.1051 
1.1057 
1.1056 
1.1073 
1.1089 
1.1073 
1.1064 
 
 
 
 
 0.0012 
 
 
 
 
 0.1138 
Table No: 17 
 
LOD and LOQ (HPLC with internal standard) 
 
 
S.No Parameter Aceclofenac Paracetamol Chlorzoxazone 
1 LOD 0.91 µg/ml 0.89 µg/ml 1.82 µg/ml 
2 LOQ 3.1 µg/ml 3.03 µg/ml 5.9µg/ml 
 
Table No: 18 
System suitability parameters (HPLC with internal standard) 
 
 
S.No 
 
Parameter 
 
Paracetamol
 
Atorvastatin
 
Chlorzoxazone 
 
Aceclofenac
 
1 Capacity 
factor 
1.5 1.8 2.1 3.09 
2 Asymmetry 
factor 
1.09 1.02 1.12 1.16 
3 Theoretical 
plates/meter 
24548 46839 69693 76793 
4 Linearity 100-500 
µg/ml 
- 100-500 µg/ml 20-100 
µg/ml 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
The separation of aceclofenac, paracetamol and chlorzoxazone by 
HPLC method has been carried out in two ways. The first method was 
performed without being using the internal standard while the second 
method has been performed by using the internal standard. Since the 
drugs were polar in nature, reverse phase chromatographic method has 
been developed. In both the methods the separation has been carried out 
by using the phenomenex ODS C18 column.  
Various solvent systems has been tried in order to obtain adequate 
resolution and good peak shape. The development of the chromatogram 
using the mobile phase methanol and water (75:25) at pH 4.5 results in 
good resolution between the peaks but the peak of aceclofenac is more 
asymmetric.  
The separation using the same mobile phase at pH 3 results in 
good resolution but the peak shape of aceclofenac is still asymmetric. 
The mobile phase was then changed to acetonitrile and water ( 60 : 40 
pH 3) results in good peak shapes for all the three drugs as evidenced by 
the asymmetric factor, but the resolution between paracetamol and 
aceclofenac is not good. 
 
The polarity of this mobile phase was then slightly decreased by 
increasing the concentration of acetonitrile (acetonitrile: water 65:35 
pH3) which results in good resolution between three peaks and the peak 
shape is more symmetric as evidenced by the resolution and asymmetric 
factor. 
The calibration curve was linear in the range by 20-100 µg per 
milliliter for aceclofenac and 100-500 µg per milliliter for paracetamol 
and chlorzoxazone. Further the co-relation co-efficient for aceclofenac 
is 0.993, paracetamol is 0.9999 and chlorzoxazone is 0.9999.Proved 
good linearity between concentration and area. 
 A robust and sensitive method was developed for the analysis of 
drugs in formulation by HPLC. 
Atorvastatin was chosen as the internal standard for the estimation 
of aceclofenac, paracetamol and chlorzoxazone. Atorvastatin was 
selected based on its polarity and its absorption in the UV region. The 
solvent system acetonitrile: water 65:35 at pH3 provides adequate 
resolution and good peak symmetry as evidenced by the resolution and 
symmetric factor. 
The calibration curve was linear in the range by 20-100 µg per 
milliliter for aceclofenac and 100-500 µg per milliliter for paracetamol 
and chlorzoxazone. Further the co-relation co-efficient for aceclofenac 
is 0.9993, paracetamol is 0.9997 and chlorzoxazone is 0.9999.Proved 
good linearity between concentration and area. 
The comparison of the statistical parameters between both of this 
estimation showed that there is no significant difference between these 
methods. The results indicate that the developed method is highly robust 
and can be used without the internal standard.   
The advantages of the developed HPLC method includes the 
isocratic separation of all the three drugs and the use of methanol for the 
extraction which has the UV cut off less than 210 nm results in good 
recovery. Also the developed method is fast and specific with no 
interference with the adjectives in the formulation. 
HPTLC. 
In HPTLC method, different mobile phases were tried in order to 
attain adequate resolution. The separation using chloroform, methanol 
and ammonia (48:11:05) results in poor resolution between aceclofenac 
and paracetamol as evidenced by the Rf values of 0.60 and 0.62.  
The chromatogram was then developed using the mobile phase 
toluene, ethyl acetate and glacial acetic acid in the ratio of 15:10:05 
results in a poor resolution between paracetamol (Rf =0.17) and 
chlorzoxazone(Rf =0.3). 
The polarity of the mobile phase is then decreased by increasing 
the concentration of toluene (toluene, ethyl acetate and glacial acetic 
acid in the ratio of 15:10:0.2) was tried which produces good resolution 
aceclofenac (0.30) and chlorzoxazone (0.72) but the resolution between 
the paracetamol (0.19) and aceclofenac is (0.30). 
The polarity and pH of the mobile phase is then decreased and the 
chromatogram is developed by using the mobile phase toluene, 
ethylacetate and glacial acetic acid in the ratio of (17.5:10:05) results in 
good separation between the drugs paracetamol, aceclofenac and 
chlorzoxazone as evidenced by the Rf values 0.12, 0.29, 0.72 
respectively. This mobile phase was then taken for the further studies. 
The calibration curve was linear in the range of 0.1mg/ml 
to0.5mg/ml for aceclofenac and 0.5mg/ml to 2-5mg/ml for paracetamol 
and chlorzoxazone. The correlation coefficient 0.9979, 0.9999 and 
0.9998 for the drugs indicates good linearity between the concentration 
and area. The amount of aceclofenac, paracetamol and chlorzoxazone 
estimated by this method is in good with label claim. The method allows 
reliable quantification of aceclofenac, paracetamol, and chlorzoxazone 
up to respectively. Statistical analysis proves that the method is 
repeatable, selective and accurate for the estimation of the drugs in the 
formulation. 
UV-DIFFERENCE SPECTROSCOPY: 
In difference spectrometry the UV-spectrum of aceclofenac is 
measured in 0.1M hydrochloric acid and 0.1M sodium hydroxide. The 
λmax of aceclofenac occurs at 272nm in 0.1M hydrochloric acid 
whereas the peak is shifted to 218nm in case of 0.1M sodium hydroxide. 
The difference absorbance is measured at 272nm since better linearity is 
obtained at this wavelength. 
The difference spectrometric absorbance was linear in the range 
of 0.96µg/ml to96µg/ml. further the co-relation co-efficient of for 
aceclofenac shows good linearity between the concentration and 
differential absorbance (ΔA). 
The results from the analysis of market sample reveals that the 
proposed method is in good agreement with the labeled amount. The 
recovery percentage from to were satisfactory which showed the 
reliability and suitability of the proposed method. 
SUMMARY AND CONCLUSION 
The formulation containing aceclofenac 100mg, paracetamol 500 
mg and chlorzoxazone 500 mg were estimated by RP-HPLC and 
HPTLC methods. The chromatographic conditions like detection 
wavelength, the composition of mobile phase, the pH of the mobile 
phase were optimized for the best possible separation of these drugs in 
the formulation. The drug formulation is then estimated using the 
optimized chromatographic conditions and the comparative datas were 
given in the table.  
Aceclofenac was estimated by differential spectropphotometric 
method. The results obtained by these methods including recovery 
studies were comparable which proves the repeatability and suitability 
of the methods. 
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